Natco Pharma advances on raising Rs 915 crore through QIP

15 Dec 2017 Evaluate

Natco Pharma is currently trading at Rs. 1047.85, up by 27.00 points or 2.64% from its previous closing of Rs. 1020.85 on the BSE.

The scrip opened at Rs. 1034.85 and has touched a high and low of Rs. 1061.95 and Rs. 1034.85 respectively. So far 2,620 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1080.00 on 09-Jun-2017 and a 52 week low of Rs. 555.50 on 26-Dec-2016.

Last one week high and low of the scrip stood at Rs. 1061.95 and Rs. 931.70 respectively. The current market cap of the company is Rs. 18,233.00 crore.

The promoters holding in the company stood at 51.19%, while Institutions and Non-Institutions held 26.94% and 21.87% respectively.

Natco Pharma has raised Rs 915 crore through issue of securities to Qualified Institutional Investors. The company’s committee of directors decided to allocate 1 crore shares at issue price of Rs 915 per share. The shares were allotted to eligible qualified institutional buyers pursuant to the QIP amounting to an issue size of Rs 915 crore.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×